Literature DB >> 27237728

Two successive calcium-dependent transitions mediate membrane binding and oligomerization of daptomycin and the related antibiotic A54145.

Robert Taylor1, Khalida Butt1, Bradley Scott1, TianHua Zhang1, Jawad K Muraih2, Evan Mintzer3, Scott Taylor4, Michael Palmer5.   

Abstract

Daptomycin and A54145 are homologous lipopeptide antibiotics that permeabilize the cell membranes of Gram-positive bacteria. Membrane permeabilization depends on the presence of both phosphatidylglycerol (PG) and calcium, and it involves the formation of oligomeric transmembrane pores that consist of approximately 6-8 subunits. We here show that each lipopeptide molecule binds two calcium ions in separable, successive steps. The first calcium ion causes the lipopeptide molecule to bind to the target membrane, and likely to form a loosely associated oligomer. Higher calcium concentrations induce binding of a second ion, which produces the more tightly associated and more deeply membrane-inserted final, functional form of the oligomer. Both calcium-dependent steps are accompanied by fluorescence signals that indicate transition of specific amino acid residues into less polar environments, suggestive of insertion into the target membrane. Our findings agree with the earlier observation that two of the four acidic amino acid residues in the daptomycin molecule are essential for antibacterial activity.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotics; Calorimetry; Fluorescence; Lipid membranes; Lipopeptides

Mesh:

Substances:

Year:  2016        PMID: 27237728     DOI: 10.1016/j.bbamem.2016.05.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Molecular State of the Membrane-Active Antibiotic Daptomycin.

Authors:  Ming-Tao Lee; Wei-Chin Hung; Meng-Hsuan Hsieh; Hsiung Chen; Yu-Yung Chang; Huey W Huang
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

2.  Daptomycin-Phosphatidylglycerol Domains in Lipid Membranes.

Authors:  Mark A Kreutzberger; Antje Pokorny; Paulo F Almeida
Journal:  Langmuir       Date:  2017-11-13       Impact factor: 3.882

3.  Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains.

Authors:  Anna Müller; Michaela Wenzel; Henrik Strahl; Fabian Grein; Terrens N V Saaki; Bastian Kohl; Tjalling Siersma; Julia E Bandow; Hans-Georg Sahl; Tanja Schneider; Leendert W Hamoen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

4.  Daptomycin Pore Formation and Stoichiometry Depend on Membrane Potential of Target Membrane.

Authors:  Gabriela Seydlová; Albert Sokol; Petra Lišková; Ivo Konopásek; Radovan Fišer
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

5.  Membrane Binding and Oligomerization of the Lipopeptide A54145 Studied by Pyrene Fluorescence.

Authors:  TianHua Zhang; Scott D Taylor; Michael Palmer; Jean Duhamel
Journal:  Biophys J       Date:  2016-09-20       Impact factor: 4.033

Review 6.  The Antibiotic Peptide Daptomycin Functions by Reorganizing the Membrane.

Authors:  Antje Pokorny; Paulo F Almeida
Journal:  J Membr Biol       Date:  2021-02-23       Impact factor: 1.843

7.  Phosphate Ions Alter the Binding of Daptomycin to Living Bacterial Cell Surfaces.

Authors:  Lindsey N Miller; Marea J Blake; Eleanor F Page; Hannah B Castillo; Tessa R Calhoun
Journal:  ACS Infect Dis       Date:  2021-10-03       Impact factor: 5.578

8.  Mitochondria-targeted antioxidants as highly effective antibiotics.

Authors:  Pavel A Nazarov; Ilya A Osterman; Artem V Tokarchuk; Marina V Karakozova; Galina A Korshunova; Konstantin G Lyamzaev; Maxim V Skulachev; Elena A Kotova; Vladimir P Skulachev; Yuri N Antonenko
Journal:  Sci Rep       Date:  2017-05-03       Impact factor: 4.379

Review 9.  More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin.

Authors:  Declan Alan Gray; Michaela Wenzel
Journal:  Antibiotics (Basel)       Date:  2020-01-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.